Helix BioPharma Corp banner

Intrinsic Value

Is HBP undervalued or overvalued?

See the intrinsic value estimate for Helix BioPharma Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

HBP Intrinsic Value
LOCKED
Unlock
Today vs. history

HBP looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with HBP’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor HBP
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price CA$0.99
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to HBP

Fundamental Analysis

What Helix BioPharma Does

Biotechnology Health Care

Helix BioPharma Corp is a Canadian biotechnology company focused on developing new cancer treatments, especially immunotherapies for solid tumors. Its main work is to design and test drug candidates rather than sell approved medicines, so the company sits at the research-and-development stage of the drug pipeline.

Headquarters
Canada CA
Employees
7
IPO date
Jun 3, 1996
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Helix BioPharma Corp

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one HBP stock?

The intrinsic value for Helix BioPharma Corp (HBP) under the Base Case is hidden CAD.

Is HBP stock undervalued or overvalued?

Compared with the current market price of 0.99 CAD, the stock appears hidden.

Back to Top